These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 17680883)
1. Oestrogen regulates the expression and function of dopamine transporters in astrocytes of the nigrostriatal system. Karakaya S; Kipp M; Beyer C J Neuroendocrinol; 2007 Sep; 19(9):682-90. PubMed ID: 17680883 [TBL] [Abstract][Full Text] [Related]
2. Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition. McArthur S; Murray HE; Dhankot A; Dexter DT; Gillies GE J Neurochem; 2007 Feb; 100(3):678-92. PubMed ID: 17116232 [TBL] [Abstract][Full Text] [Related]
3. Age-related changes in nigrostriatal dopaminergic function in heterozygous mutant dopamine transporter knock-out mice. Dluzen DE; Ji J; McDermott JL Neurosci Lett; 2010 May; 476(2):66-9. PubMed ID: 20382201 [TBL] [Abstract][Full Text] [Related]
4. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease. Afonso-Oramas D; Cruz-Muros I; Alvarez de la Rosa D; Abreu P; Giráldez T; Castro-Hernández J; Salas-Hernández J; Lanciego JL; Rodríguez M; González-Hernández T Neurobiol Dis; 2009 Dec; 36(3):494-508. PubMed ID: 19766189 [TBL] [Abstract][Full Text] [Related]
5. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. González-Hernández T; Barroso-Chinea P; De La Cruz Muros I; Del Mar Pérez-Delgado M; Rodríguez M J Comp Neurol; 2004 Nov; 479(2):198-215. PubMed ID: 15452855 [TBL] [Abstract][Full Text] [Related]
6. Genetic alteration in the dopamine transporter differentially affects male and female nigrostriatal transporter systems. Ji J; Bourque M; Di Paolo T; Dluzen DE Biochem Pharmacol; 2009 Dec; 78(11):1401-11. PubMed ID: 19615345 [TBL] [Abstract][Full Text] [Related]
7. Nigrostriatal cell firing action on the dopamine transporter. Rodriguez M; Gonzalez S; Morales I; Sabate M; Gonzalez-Hernandez T; Gonzalez-Mora JL Eur J Neurosci; 2007 May; 25(9):2755-65. PubMed ID: 17561841 [TBL] [Abstract][Full Text] [Related]
8. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain. Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466 [TBL] [Abstract][Full Text] [Related]
10. Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum. Singh S; Singh K; Gupta SP; Patel DK; Singh VK; Singh RK; Singh MP Brain Res; 2009 Aug; 1283():115-26. PubMed ID: 19520064 [TBL] [Abstract][Full Text] [Related]
11. Influence of oestrogenic compounds on monoamine transporters in rat striatum. Le Saux M; Di Paolo T J Neuroendocrinol; 2006 Jan; 18(1):25-32. PubMed ID: 16451217 [TBL] [Abstract][Full Text] [Related]
12. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA. Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311 [TBL] [Abstract][Full Text] [Related]
13. Oestrogen and progesterone reduce lipopolysaccharide-induced expression of tumour necrosis factor-alpha and interleukin-18 in midbrain astrocytes. Kipp M; Karakaya S; Johann S; Kampmann E; Mey J; Beyer C J Neuroendocrinol; 2007 Oct; 19(10):819-22. PubMed ID: 17850464 [TBL] [Abstract][Full Text] [Related]
14. Oestrogen influences on mitochondrial gene expression and respiratory chain activity in cortical and mesencephalic astrocytes. Araújo GW; Beyer C; Arnold S J Neuroendocrinol; 2008 Jul; 20(7):930-41. PubMed ID: 18445124 [TBL] [Abstract][Full Text] [Related]
15. Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter. Wersinger C; Sidhu A Biochemistry; 2005 Oct; 44(41):13612-24. PubMed ID: 16216085 [TBL] [Abstract][Full Text] [Related]
16. AQP4 expression in striatal primary cultures is regulated by dopamine--implications for proliferation of astrocytes. Küppers E; Gleiser C; Brito V; Wachter B; Pauly T; Hirt B; Grissmer S Eur J Neurosci; 2008 Dec; 28(11):2173-82. PubMed ID: 19046364 [TBL] [Abstract][Full Text] [Related]
17. Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity. Bourque M; Liu B; Dluzen DE; Di Paolo T Biochem Pharmacol; 2007 Nov; 74(9):1413-23. PubMed ID: 17825264 [TBL] [Abstract][Full Text] [Related]
18. Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture. Yamamoto H; Kamegaya E; Hagino Y; Imai K; Fujikawa A; Tamura K; Enokiya T; Yamamoto T; Takeshima T; Koga H; Uhl GR; Ikeda K; Sora I Neurochem Int; 2007; 51(2-4):237-44. PubMed ID: 17664021 [TBL] [Abstract][Full Text] [Related]
19. Reduced expression and capacity of the striatal high-affinity choline transporter in hyperdopaminergic mice. Parikh V; Apparsundaram S; Kozak R; Richards JB; Sarter M Neuroscience; 2006 Aug; 141(1):379-89. PubMed ID: 16675138 [TBL] [Abstract][Full Text] [Related]
20. Astroglial dopamine transport is mediated by norepinephrine transporter. Takeda H; Inazu M; Matsumiya T Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):620-3. PubMed ID: 12444505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]